INNT
TOTAL INVALIDATION PROCESSED BY THE IB
05/24/2025
Back to search
Official data from USPTO
PREXTON THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
05/25/2025
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
03/16/2017
Registration date
11/28/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/14/2024
Last transaction
05/25/2025
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
DK
Examiner
BROWN, TINA
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a teardrop shape containing a circle divided into three sections to the left of the word "PREXTON" above the word "THERAPEUTICS" in stylized font.
Holders and representatives
Holders
H. Lundbeck A/S
Prexton Therapeutics SA
Representatives
Douglas R. Wolf Wolf, Greenfield & Sacks, P.C.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productspharmaceutical preparations for the treatment of Parkinson's disease
Class 42
Scientific and technological services as well as researchscientific research concerning the treatment of Parkinson's disease; design and development services in the medical and pharmaceutical fieldproduct developmentnew product design services and pharmaceutical products development concerning the treatment of Parkinson's disease; development of medicines for others; medicine discovery servicespharmaceutical research and development concerning the treatment of Parkinson's disease
Class 44
Services provided by consultants in the medical and pharmaceutical fieldmedical consultationsconsulting services in the field of healthmedical informationpharmaceutical advice concerning the treatment of Parkinson's disease; consultancy services in the field of medical treatments and provision of advice in the pharmaceutical fieldproviding information relating to medical testing for diagnostic or treatment purposesconsulting services relating to medical treatment of Parkinson's diseasepharmaceutical advice
Publications
History of USPTO decisions and trademark events.
31 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
05/03/2025
INPC
INVALIDATION PROCESSED
05/02/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
02/14/2025
C71T
CANCELLED SECTION 71
06/14/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/28/2022
CHLD
CHANGE OF OWNER RECEIVED FROM IB
08/13/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/04/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/15/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/13/2018
FIMP
FINAL DISPOSITION PROCESSED
03/13/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/28/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
11/28/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/12/2017
PUBO
PUBLISHED FOR OPPOSITION
09/12/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/23/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/05/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/04/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/04/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/04/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/03/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/03/2017
RFNT
REFUSAL PROCESSED BY IB
07/08/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/19/2017
RFRR
REFUSAL PROCESSED BY MPU
06/19/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/10/2017
CNRT
NON-FINAL ACTION WRITTEN
06/09/2017
DOCK
ASSIGNED TO EXAMINER
06/09/2017
MAFR
APPLICATION FILING RECEIPT MAILED
05/30/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/26/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/25/2017
Continuous trademark protection
Get notified about every new filing that threatens PREXTON THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.